Skip to main content
Clinical Trials/CTRI/2024/04/065538
CTRI/2024/04/065538
Not Yet Recruiting
N/A

asal intermittent positive pressure ventilation (NIPPV) versus nasal Continuous positive airway pressure (NCPAP) as a primary respiratory support for preterm infants (=34 weeks) – A Randomized Control Trial - NI

ational Institute of Medical Science and Research Jaipur Rajasthan India0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Medical Science and Research Jaipur Rajasthan India
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Medical Science and Research Jaipur Rajasthan India

Eligibility Criteria

Inclusion Criteria

  • Neonates fulfilling all the following criteria
  • 1\. Preterm infants (gestational age \= 34 weeks)
  • 2\. Presenting to NICU within 6 hours of birth
  • 3\. Respiratory distress, defined as Silverman Andersen Respiratory Severity Score (SAS
  • score \=3/10\)
  • 4\. Babies whose parents/Guardians have given informed consent

Exclusion Criteria

  • Anyone of the following
  • 1\. Major congenital anomaly (antenatally diagnosed or visible at birth)
  • 2\. Presence of severe Hemodynamic instability before randomization. \[Vasopressor
  • inotrope index \= 10 that is dopamine (\= 10 mcg/kg/min), dobutamine (\= 10 mcg/kg/min), epinephrine (\= 0\.1 mcg/kg/min), norepinephrine (\= 0\.1 mcg/kg/min), vasopressin (\= 0\.001 IU/kg/min) and milrinone (\= 0\.1 mcg/kg/min)]
  • 3\. Baby intubated at or before admission to NICU

Outcomes

Primary Outcomes

Not specified

Similar Trials